Here, David Maloney, MD, PhD, of Fred Hutchinson Cancer Research Center, Seattle, WA, tells us what’s in store at the 2019 iwCAR-T Meeting to be held in Miami, FL, in October and how it will enable discussions on key areas of CAR T-cell therapy such as the management of toxicity and long-term follow ups. Prof. Maloney highlights how it will also allow experts in the field to learn from each other’s experiences. This interview was taken at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.